We Look Forward to Helping You:  609.315.2787

Opening The Digital Front Door in Telehealth

November 12, 2020

The “Digital Front Door” is a new integrated digital experience that empowers people to take an active role in managing their health.  It is based on the use of personalized mobile and web platforms, many of them created by start-ups.  Spurred by COVID-19, established healthcare systems have forged relationships with these start-ups, opening the door to enhanced care.

Read More

Venture Debt is a Growing Option for Start-ups

November 6, 2020

Venture Debt is a growing option for start-ups to access growth capital, while maintaining founder equity.  The terms of Venture Debt include fixed repayment with interest secured by company assets, with a mild equity twist.  This is a welcome trend, although piggy-backing on the prior infusion and support of Venture Capital.


Read More

Hybrid Independent Contractor Model Emerges

November 5, 2020

Uber, Lyft and DoorDash have successfully obtained the CA vote to retain their workers as independent contractors, but they conceded to providing some “employee” benefits to obtain this milestone vote. This may be the beginning of a new model for independent contractor talent hiring in the growing gig ecosystem.


Read More

SEC to Expand Crowdfunding Investment Pool

November 4, 2020

The SEC recently voted to expand its mission to help small business fundraise in private markets by increasing the threshold crowdfunding amount to $5M and the amounts that the non-accredited can invest.  This new access is expected to boost entrepreneurship, now ever more present in our new normal of COVID-19.


Read More

Debt of Single Asset Real Estate entity blows Subchapter V Eligibility

November 3, 2020

A recent bankruptcy court decision has found the debt of an affiliate that is ineligible to file for Subchapter V to be included in the $7.5M threshold for eligibility (and post-CARES Act, a $2.7M threshold).  In this case, the affiliate was a single asset real estate entity.  This decision appears counterintuitive.  Stay tuned for an appeal?


Read More

The Catch 22 in Crowdfunding Campaigns

November 2, 2020

A recent study shows that crowdfunding psychology requires a unique fundraising strategy.  An abundance of early donations is viewed as originating from friends and family who have not scrutinized the deal, while the opposite is inferred from a lean start.  Balancing this perception from day 1 is key to a successful campaign.

Read More

PPP Recipients can Self-Certify for Small Loan Forgiveness

October 30, 2020
Thankfully, the SBA has issued new guidelines for PPP loan forgiveness with the following changes.  Recipients of $50,000 or less can self-certify that the money was used for covered expenses, the new application is one page short, and the requirement to maintain employee and salary numbers has been eliminated.  This is a great step toward accomplishment of PPP goals!
Read More

Title VII Loophole Allowing Bank Discrimination May be Soon be Closed

October 29, 2020

banks to treat customers differently.  While many states prohibit bank discrimination, the disparity necessitates a federal fix.


Read More

The Right to Repair Movement embraces Mobile Health

October 28, 2020

On a consumer plug today, I am excited by the “right to repair” trend that has surfaced in a proposed bill to block manufacturer imposed limits on medical device repair.  While advocates worry about the environment, an important fall-out is consumer inability to take ownership of product maintenance.  Of course safety is key, and I look forward to contributions by regulators and thought leaders in mHealth and other fields.



Read More

How Intrapreneurship is playing out in the race toward a COVID-19 vaccine

October 22, 2020

Wearing my digital health professor hat, I am sharing this article about the legal, social and political dynamics involved in forging a licensing deal between Oxford scientist inventor-founders of start-up Vaccitech, academia and big pharma AstraZeneca with the twin goal of profit and global access for a COVID-19 vaccine.


Read More